ArticleNpj viruses2026
Hemagglutinin E190D substitution in clade 2.3.4.4b A(H5N1) influenza virus reduces receptor binding and viral fitness.
Article in Npj viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- H5N1 influenza binding and cell entry via human class II MHC, and blocking by cross-reactive antibodies.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The detection of a clade 2.3.4.4b influenza A(H5N1) virus bearing an HA-E190D substitution in an infected human raises concern about mammalian adaptation. We evaluated the impact of the naturally occurring HA-E190D substitution in the A/British Columbia/PHL-2032/2024 (BC/24) virus on receptor binding specificity and viral fitness in vitro and in vivo. Recombinant BC/24 HA-E190D protein retained α2,3-linked sialic acid binding specificity but with reduced binding affinity. In cell culture, BC/24 viruses dominated by HA-190D were frequently outcompeted by the minor HA-190E variant in the inoculum, whereas BC/24 HA-190E viruses maintained dominance in the presence of residual HA-190D in the inoculum. In ferrets, BC/24 HA-190D viruses were similarly outcompeted by HA-190E; in one out of six ferrets where HA-190D dominance persisted, the virus was attenuated and failed to spread systemically. In contrast, BC/24 HA-190E viruses maintained dominance and disseminated systemically. These results indicate that the BC/24 variant bearing HA-E190D substitution did not acquire human-like receptor binding specificity and was less fit in mammalian hosts, making it unlikely to enhance public health risk without additional compensatory mutations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.